RLMD
Relmada TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
RLMD vs peer average
66/100
RLMD vs. peer average (C vs. D)
Grade spread
B 1 · C 1 · D 3 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
CABA is the first available peer comparator.
Loose same-sector, similar-market-cap biotech comparator; not indication matched, so valuation comparison is limited.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
RLMD
Relmada Therapeutics
CABA
Cabaletta Bio
Grade
C
D
Momentum
4
64
Value
41
41
Sentiment
77
45
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs CABA
RLMD / CABA
Grade Position
In line
RLMD vs. peer average (C vs. D)
66/100
Momentum
4
CABAValue
41
RLMDSentiment
77
RLMDRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs RLMD
CABA is the first peer returned for this comparison set.